SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Aaron M. Bender, Nicholas W. Griggs, Jessica P. Anand, John R. Traynor, Emily M. Jutkiewicz, Henry I. Mosberg, Asymmetric Synthesis and in Vitro and in Vivo Activity of Tetrahydroquinolines Featuring a Diverse Set of Polar Substitutions at the 6 Position as Mixed-Efficacy μ Opioid Receptor/δ Opioid Receptor Ligands, ACS Chemical Neuroscience, 2015, 150513151248008

    CrossRef

  2. 2
    Juan Pablo Cueva, Christopher Roche, Mehrnoosh Ostovar, Vinod Kumar, Mary J. Clark, Todd M. Hillhouse, John W. Lewis, John R. Traynor, Stephen M. Husbands, C7β-Methyl Analogues of the Orvinols: The Discovery of Kappa Opioid Antagonists with Nociceptin/Orphanin FQ Peptide (NOP) Receptor Partial Agonism and Low, or Zero, Efficacy at Mu Opioid Receptors, Journal of Medicinal Chemistry, 2015, 58, 10, 4242

    CrossRef

  3. 3
    Mehr-un-Nisa, Munawar A. Munawar, Yeon Sun Lee, David Rankin, Jawaria Munir, Josephine Lai, Misbahul A. Khan, Victor J. Hruby, Design, synthesis, and biological evaluation of a series of bifunctional ligands of opioids/SSRIs, Bioorganic & Medicinal Chemistry, 2015, 23, 6, 1251

    CrossRef

  4. 4
    Grazyna Weltrowska, Carole Lemieux, Nga N. Chung, Jason J. Guo, Brian C. Wilkes, Peter W. Schiller, ‘Carba’-carfentanil (trans isomer): A μ opioid receptor (MOR) partial agonist with a distinct binding mode, Bioorganic & Medicinal Chemistry, 2014, 22, 17, 4581

    CrossRef

  5. 5
    Henry I. Mosberg, Larisa Yeomans, Jessica P. Anand, Vanessa Porter, Katarzyna Sobczyk-Kojiro, John R. Traynor, Emily M. Jutkiewicz, Development of a Bioavailable μ Opioid Receptor (MOPr) Agonist, δ Opioid Receptor (DOPr) Antagonist Peptide That Evokes Antinociception without Development of Acute Tolerance, Journal of Medicinal Chemistry, 2014, 57, 7, 3148

    CrossRef

  6. 6
    Vinod Kumar, Irna E. Ridzwan, Konstantinos Grivas, John W. Lewis, Mary J. Clark, Claire Meurice, Corina Jimenez-Gomez, Irina Pogozheva, Henry Mosberg, John R. Traynor, Stephen M. Husbands, Selectively Promiscuous Opioid Ligands: Discovery of High Affinity/Low Efficacy Opioid Ligands with Substantial Nociceptin Opioid Peptide Receptor Affinity, Journal of Medicinal Chemistry, 2014, 57, 10, 4049

    CrossRef

  7. 7
    Aaron M. Bender, Mary J. Clark, Michael P. Agius, John R. Traynor, Henry I. Mosberg, Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands, Bioorganic & Medicinal Chemistry Letters, 2014, 24, 2, 548

    CrossRef

  8. 8
    Jessica P. Anand, Vanessa R. Porter-Barrus, Helen V. Waldschmidt, Larisa Yeomans, Irina D. Pogozheva, John R. Traynor, Henry I. Mosberg, Translation of structure-activity relationships from cyclic mixed efficacy opioid peptides to linear analogues, Peptide Science, 2014, 102, 1
  9. 9
    Richard J. Bodnar, Endogenous opiates and behavior: 2012, Peptides, 2013, 50, 55

    CrossRef

  10. 10
    Grazyna Weltrowska, Thi M.-D. Nguyen, Nga N. Chung, Brian C. Wilkes, Peter W. Schiller, N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile, Bioorganic & Medicinal Chemistry Letters, 2013, 23, 18, 5082

    CrossRef

  11. 11
    Henry I. Mosberg, Larisa Yeomans, Aubrie A. Harland, Aaron M. Bender, Katarzyna Sobczyk-Kojiro, Jessica P. Anand, Mary J. Clark, Emily M. Jutkiewicz, John R. Traynor, Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy μ Opioid Receptor (MOR) Agonist/δ Opioid Receptor (DOR) Antagonist Ligands, Journal of Medicinal Chemistry, 2013, 56, 5, 2139

    CrossRef